| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.194 | 11.943 | 21.720 | 29.725 | 45.826 | 62.523 | 78.287 | 92.675 | 97.553 |
| Total Income - EUR | - | 3.194 | 11.943 | 21.720 | 29.725 | 45.827 | 62.523 | 78.442 | 92.770 | 97.663 |
| Total Expenses - EUR | - | 10.027 | 11.701 | 15.417 | 21.340 | 25.899 | 29.427 | 29.707 | 24.895 | 35.942 |
| Gross Profit/Loss - EUR | - | -6.833 | 242 | 6.304 | 8.385 | 19.927 | 33.096 | 48.735 | 67.875 | 61.721 |
| Net Profit/Loss - EUR | - | -6.897 | 122 | 6.087 | 8.087 | 19.500 | 32.625 | 47.968 | 66.967 | 58.853 |
| Employees | - | 1 | 1 | 1 | 2 | 3 | 3 | 2 | 1 | 1 |
Check the financial reports for the company - Cabinet Diabet - Nutriţie Dr. Dănălache Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 310 | 0 | 1.532 | 1.040 | 567 | 111 | 0 | 10.899 | 55.318 |
| Current Assets | - | 2.183 | 1.282 | 2.421 | 7.700 | 20.543 | 33.860 | 54.102 | 79.801 | 81.724 |
| Inventories | - | 63 | 62 | 61 | 60 | 59 | 57 | 58 | 57 | 77 |
| Receivables | - | 605 | 1.027 | 1.669 | 6.982 | 15.301 | 23.451 | 34.924 | 72.528 | 59.928 |
| Cash | - | 1.515 | 193 | 691 | 658 | 5.183 | 10.352 | 19.120 | 7.216 | 21.718 |
| Shareholders Funds | - | -6.852 | -6.614 | -406 | 7.689 | 19.550 | 32.674 | 48.017 | 67.015 | 58.902 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 9.347 | 7.896 | 4.359 | 1.051 | 1.574 | 1.311 | 6.085 | 23.798 | 78.457 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Diabet - Nutriţie Dr. Dănălache Srl